BRPI1013184A2 - método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral - Google Patents

método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral

Info

Publication number
BRPI1013184A2
BRPI1013184A2 BRPI1013184A BRPI1013184A BRPI1013184A2 BR PI1013184 A2 BRPI1013184 A2 BR PI1013184A2 BR PI1013184 A BRPI1013184 A BR PI1013184A BR PI1013184 A BRPI1013184 A BR PI1013184A BR PI1013184 A2 BRPI1013184 A2 BR PI1013184A2
Authority
BR
Brazil
Prior art keywords
identifying
treatment
condition
oral cavity
compound usable
Prior art date
Application number
BRPI1013184A
Other languages
English (en)
Inventor
Harsh M Trivedi
Tao Xu
Ying Yang
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BRPI1013184A2 publication Critical patent/BRPI1013184A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1013184A 2009-04-01 2010-04-01 método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral BRPI1013184A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01
PCT/US2010/029674 WO2010115034A2 (en) 2009-04-01 2010-04-01 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Publications (1)

Publication Number Publication Date
BRPI1013184A2 true BRPI1013184A2 (pt) 2016-04-12

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013184A BRPI1013184A2 (pt) 2009-04-01 2010-04-01 método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral

Country Status (15)

Country Link
US (1) US8753820B2 (pt)
EP (1) EP2414837B1 (pt)
JP (1) JP5643288B2 (pt)
CN (1) CN102549432B (pt)
AR (1) AR076041A1 (pt)
BR (1) BRPI1013184A2 (pt)
CA (1) CA2753718C (pt)
CO (1) CO6430490A2 (pt)
MX (1) MX2011008439A (pt)
MY (1) MY179250A (pt)
RU (1) RU2523383C2 (pt)
SG (1) SG173461A1 (pt)
TW (1) TWI481870B (pt)
WO (1) WO2010115034A2 (pt)
ZA (1) ZA201106056B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076177A1 (es) * 2009-04-01 2011-05-26 Colgate Palmolive Co MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
US20190339269A1 (en) * 2017-01-03 2019-11-07 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
JP7152423B2 (ja) * 2017-05-24 2022-10-12 コーニンクレッカ フィリップス エヌ ヴェ 唾液のｉｌ－１ベータ及びｈｇｆに基づく歯肉炎の診断
CA3064328A1 (en) * 2017-05-24 2018-11-29 Koninklijke Philips N.V. Diagnostics of periodontitis based on salivary hgf and mmp-8
CN111226118A (zh) 2017-10-27 2020-06-02 加利福尼亚大学董事会 用于牙龈炎的唾液细胞外rna生物标记物
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
DE59704397D1 (de) 1996-06-12 2001-09-27 Cognis Deutschland Gmbh Kosmetische und/oder pharmazeutische zubereitungen
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
EP1234181A4 (en) 1999-12-03 2005-01-26 Baxter Int PYROGENICITY TEST FOR USE WITH AUTOMATED IMMUNOLOGICAL ASSAY SYSTEMS
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
EP1285092A4 (en) 2000-04-14 2003-07-16 Metabolon Inc METHOD FOR DISCOVERY OF MEDICINES, DISEASE TREATMENT AND DIAGNOSIS USE THE METABOLOMICS
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
PL378108A1 (pl) 2003-02-14 2006-03-06 Combinatorx, Incorporated Leczenie łączone do terapii zapalnych zaburzeń immunologicznych
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
US7202234B2 (en) 2003-10-24 2007-04-10 Eisai Co., Ltd. Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
ES2320139T3 (es) 2003-12-03 2009-05-19 Whitehead Institute For Biomedical Research Uso de t-cadherina soluble para el tratamiento de trastornos metabolicos.
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
WO2006068133A1 (ja) * 2004-12-21 2006-06-29 National University Corporation NARA Institute of Science and Technology Ｎｆａｔ２発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
ES2421595T3 (es) 2006-01-10 2013-09-04 Colgate Palmolive Co Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
EP2207546A1 (en) 2007-10-09 2010-07-21 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
EP2414837B1 (en) 2015-06-03
TW201102653A (en) 2011-01-16
US8753820B2 (en) 2014-06-17
TWI481870B (zh) 2015-04-21
CO6430490A2 (es) 2012-04-30
MX2011008439A (es) 2011-09-06
RU2523383C2 (ru) 2014-07-20
EP2414837A2 (en) 2012-02-08
AR076041A1 (es) 2011-05-11
US20120028261A1 (en) 2012-02-02
JP2012522994A (ja) 2012-09-27
RU2011144032A (ru) 2013-05-10
WO2010115034A2 (en) 2010-10-07
CA2753718C (en) 2015-06-23
ZA201106056B (en) 2015-05-27
CN102549432B (zh) 2015-03-25
CA2753718A1 (en) 2010-10-07
SG173461A1 (en) 2011-09-29
MY179250A (en) 2020-11-02
AU2010232593A1 (en) 2011-08-25
WO2010115034A3 (en) 2010-12-29
JP5643288B2 (ja) 2014-12-17
CN102549432A (zh) 2012-07-04

Similar Documents

Publication Publication Date Title
BRPI0919626A2 (pt) implante dental
BRPI0810555A2 (pt) Implante dentário
BRPI0916049A2 (pt) "dispositivo para tratamento da cavidade dental e método para tratamento da cavidade dental"
BRPI0917567A2 (pt) tratamento de doença respiratória
BRPI0909908A2 (pt) implante de válvula cardíaca
BRPI0915267A2 (pt) Composto, composição farmacêutica livre de pirogênio, e, método de tratamento de uma doença ou uma condição
BRPI0810554A2 (pt) Implante dentário e conexão de componente dentário
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
BRPI0910854A2 (pt) métodos de tratamento
BRPI0921659A2 (pt) metodo e sistema para formar uma protese dentaria
BRPI0815703A2 (pt) Processo de fabricação de uma prótese dentária e de um guia cirúrgico dentário.
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
BRPI0906461A2 (pt) Composição para o cuidado oral, e, método para aplicar uma composição de cuidado oral na cavidade oral
BR112012004135A2 (pt) implante dentário, e, kit de implante dentário
BR112013009970A2 (pt) método para determinar uma característica do ritmo circadiano de um paciente.
BRPI1013184A2 (pt) método de identificar um composto utilizável no tratamento de uma doença ou condição da cavidade oral
ZA201006752B (en) Spiro-indole derivatives for the treatment of parasitic disease
BRPI0819642A2 (pt) Método para a formação de uma dentadura para um paciente em uma única visita, e, dentadura
BRPI0916250A2 (pt) método para aliviar uma infecção de um tecido em uma cavidade oral
DK2265296T3 (da) Medicinske apparater med hydrofile belægninger
IT1397349B1 (it) Metodo e kit per la produzione di un prodotto dentale
BRPI1015216A2 (pt) método de tratar ou prevenir uma condição médica em um indivíduo.
BRPI0820449A2 (pt) Conjunto de implante médico interfaceado
BRPI0912560A2 (pt) método de promoção da cura de feridas
FR2908287B1 (fr) Implants dentaires monoblocs visses

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]